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JPPT
Case Report
Continuous Infusion of Nafcillin for Sternal Osteomyelitis in an Infant
After Cardiac Surgery
Chad A. Knoderer, PharmD,1,2,3 Jennifer L. Morris, PharmD,2,4 and Elaine G. Cox, MD3
Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Butler University, Indianapolis, Indiana, 2Department of Pharmacy, Riley Hospital for Children, Clarian Health, Indianapolis, Indiana, 3Department of
Pediatrics, Ryan White Center for Pediatric Infectious Disease, Indiana University School of Medicine, Indianapolis,
Indiana, and 4Department of Pharmacy Practice, Purdue University School of Pharmacy and Pharmaceutical Sciences,
Indianapolis, Indiana
1

We report the use of the continuous infusion of nafcillin for the treatment of an infant who had methicillinsusceptible Staphylococcus aureus sternal osteomyelitis not responsive to traditional nafcillin dosing. The
patient was successfully treated with surgical debridement and the continuous infusion of nafcillin. To our
knowledge, this is the first report describing the successful use of the continuous infusion of nafcillin to treat
an infant who had sternal osteomyelitis after cardiac surgery.
KEYWORDS congenital heart disease, continuous infusion, nafcillin, sternal wound infection
J Pediatr Pharmacol Ther 2010;15:49–54

BACKGROUND
Surgical site infections account for approximately 16% of hospital-acquired infections and
remain a concern in the treatment of children
undergoing surgery for the repair of congenital
heart disease.1 Sternal wound infections occur
in 5% of children who have undergone median
sternotomy. For children who have undergone
cardiac surgery, incidence of such infections is 3%
for superficial sternal infections, 2% for deep sternal infections, and 0.04%-3.9% for mediastinitis.2-5
Surgical debridement and prolonged durations
of the intravenous (IV) administration of antibiotics are the mainstays of treatment. Because of
the organisms that commonly precipitate mediastinal infections, antistaphylococcal or broad
spectrum beta-lactam antibiotics are often used
to treat these infections.3 In contrast with a similar
regimen applied in the adult population, there
are few reports of the administration of betaAddress correspondence to: Chad A. Knoderer, PharmD,
Riley Hospital for Children, 702 Barnhill Drive, Room 1016,
Indianapolis, IN, 46202, email: cknoderer@clarian.org
© 2010 Pediatric Pharmacy Advocacy Group
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lactam antibiotics via continuous IV infusion in
children and in practice is rarely used.6-8 To our
knowledge, our report is the first published case
ABBREVIATIONS ASD, atrial septal defect; CoA, coarctation
of the aorta; CPB, cardiopulmonary bypass; DOL, day of life;
IV, intravenous; MIC, minimum inhibitory concentration;
MSSA, methicillin-susceptible Staphylococcus aureus; VSD,
ventricular septal defect; WBC, white blood cell

of a patient treated with a continuous infusion
of nafcillin for sternal osteomyelitis after surgery
for congenital heart disease.

CASE REPORT
A 12-day-old, full-term, male infant with congenital heart disease that had features consistent
with Shone’s complex—coarctation of the aorta
(CoA), a hypoplastic and bicuspid aortic valve, a
mildly hypoplastic aortic arch, a secundum atrial
septal defect (ASD), and a paramembranous
ventricular septal defect (VSD)—was admitted
for increased work of breathing, shortness of
breath, and diaphoresis with feeding. His CoA
was surgically repaired on the 15th day of life
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Table. Laboratory Parameters After ASD and VSD Repair
DOL

POD ASD/VSD

31

3

32

4

33

5

34

6

35

7

36

8

37

9

38

10

39

11

40

12

41

13

42

14¶

43

15

WBC Count*
(N/B)†
11.5
(58/6)
23.9
(77/17)
13.3
(52/33)
9.4
(79/14)
6.1
(80/0)
3.4
(61/0)
6.5
(77/0)
7.4
(29/18)
11.1
(74/0)
20.2
(66/16)
16.9
(88/0)
16.9
(90/0)
13
(85/0)

Platelet Count‡

Culture Analysis Results

106

N/A

61

Blood, MSSA (+)§
Chest tube fluid, MSSA (+)

48

Blood, MSSA (+)

25

Blood, no growth

39

N/A

64

no growth

79

N/A

167

N/A

174

no growth

174

N/A

176

N/A

180

Bone, MSSA (+)
Wound, MSSA (+)

174

N/A

ASD, atrial septal defect; B, bands; DOL, day of life; MSSA, methicillin-susceptible Staphylococcus aureus; N, neutrophils; N/A , not applicable
because no specimen taken, POD, postoperative day; VSD, ventricular septal defect; WBC, white blood cells.
Ý
Calculated as No. x 103/mm3
† Percentage of neutrophils/percentage of bands
† Calculated as No. x 103/mm3
§ (+) Symbol indicates positive
¶ Continuous infusion of nafcillin initiated

(DOL), and he received an extended end-to-end
anastomosis through a thoracotomy incision.
He was admitted to the pediatric intensive care
unit for postoperative care. On the second postoperative day (DOL 17), the patient was begun
on inotropic support for hemodynamic instability; vancomycin (30 mg/kg/d divided every 12
hours) and piperacillin-tazobactam (300 mg/
kg/d divided every 8 hours) were initiated to
rule out sepsis. The patient was afebrile at this
time, and his white blood cell (WBC) count was
normal. Blood and urine cultures tested negative
for the presence of bacteria, and the antibiotics
were discontinued after 48 hours. Over the next
several days, the patient continued to exhibit
signs of heart failure and ultimately did not wean
50

from mechanical ventilation. Echocardiogram
findings showed significant left-to-right shunting through the ASD and VSD. The patient was
taken to surgery on DOL 28 for repair of his
ASD and VSD. Cardiopulmonary bypass (CPB)
and moderate hypothermia were required for
surgical repair.
After ASD and VSD repair, the infant remained mechanically ventilated in the pediatric intensive care unit. The patient received
24 hours of postoperative cefuroxime sodium
prophylaxis. On the fourth postoperative day
(DOL 32), the patient’s WBC count increased to
23.9 × 103/mm3 from 11.5 × 103/mm3, with a differential of 77% neutrophils and 17% bands. The
platelet count decreased to 61 × 103/mm3 from
J Pediatr Pharmacol Ther 2010 Vol. 15 No. 1 • www.jppt.org
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106 × 103/mm3 (Table). Chest tube (placed during ASD/VSD repair) drainage at that time was
observed to be milky in appearance, although
there was not an increase in output. Analysis of
this fluid revealed a triglyceride concentration
of 85 mg/dL, and chylothorax was ruled out.9,10
Because the patient was afebrile, antibiotics
were not started, but blood and urine cultures
were obtained. On DOL 33, the microbiological analysis showed that 3 of 4 bottles of blood
from the previous day had tested positive for
Gram-positive cocci, which were subsequently
identified as methicillin-susceptible Staphylococcus aureus (MSSA). The MSSA was resistant to
penicillin but retained susceptibility to oxacillin
with a minimum inhibitory concentration (MIC)
of 0.5 mg/L. Additional blood and urine cultures
were obtained. There was a moderate amount of
milky-appearing drainage from the chest tube
had a strong odor and was also sent for culture.
Vancomycin (30 mg/kg/d divided every 12
hours), gentamicin (4.3 mg/kg every 24 hours),
and piperacillin (250 mg/kg/d divided every 8
hours) were initiated after the new cultures were
obtained. The second set of blood cultures and
cultures of the chest tube drainage from DOL
33 also tested positive for MSSA. Vancomycin
and piperacillin were discontinued on DOL
35, and nafcillin was initiated at 170 mg/kg/d
divided every 6 hours. The maximum dose of
nafcillin was not initiated because of concerns
for potential hematologic and hepatic toxicities. Gentamicin was continued as a 4.3 mg/kg
dose every 24 hours. Serum concentrations of
gentamicin were obtained weekly and were
at so-called “therapeutic values” for low-dose
gentamicin MSSA therapy.
Over the next 2 days, the infant remained
afebrile and had a decreasing WBC count. The
chest tube output was thick and brownish. The
patient again did not wean to extubation from
mechanical ventilation on DOL 39. Erythema
was observed on DOL 41, spreading out from the
sternal wound with an area of fluctuance under
the dressing. The sternal incision had reddened,
and it had a dime-sized, fluid pocket on the upper third of the incision site. The patient went
for mediastinal exploration and debridement
the next day. Intraoperative findings showed
purulent material beneath the skin and anterior
to the sternum and it was exposed to the lower
half of the sternum. The wound infection also apJ Pediatr Pharmacol Ther 2010 Vol. 15 No. 1 • www.jppt.org
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peared to tract down toward the chest tube site.
The lowermost sternal wire was removed, as it
was partially loose, along with a small bone flap
that appeared to be partially disengaged from the
rest of the sternum. The purulent material and
bone fragment were sent for culture; they tested
positive for MSSA.
On the basis of the positive results for the
wound culture and intraoperative observations
from the mediastinal exploration, on DOL 42,
intermittent administration of nafcillin was
stopped, and continuous infusion dosing was
started to optimize the drug’s pharmacodynamic
profile. The nafcillin was dosed to provide 185
mg/kg/d, delivered as a continuous IV infusion.
This dosage was approximately the same total
daily dose that was being administered with intermittent dosing. Over the subsequent days, the
patient’s condition was stable, and the incision
had no signs of infection. An additional wound
culture obtained on DOL 49 (7 days after surgical
debridement) was negative for the presence of
bacteria. The patient was treated for an additional
12 days with gentamicin (26 days total) and 35
days of continuous infusion nafcillin (49 days
total duration). No additional signs of wound
infection were present.
The continuous infusion of nafcillin was well
tolerated. We observed no clinically significant
changes in the patient’s hepatic or hematologic
laboratory values. Although the patient had a
maculopapular rash 2 days after the initiation
of the continuous infusion of nafcillin, the rash
appeared to be caused by external contact, and
it subsided over the next several days without
discontinuation of nafcillin.
The patient had one subsequent episode of
bacteremia that occurred 14 days after discontinuation of nafcillin. Blood cultures from DOL
97 and 100 tested positive for coagulase-negative
staphylococci, which were methicillin-resistant;
the patient received treatment with vancomycin
for 10 days. Although the patient had received
antibiotics on several occasions after the discontinuation of nafcillin, no cultures yielded reoccurrence of MSSA.
The patient continued with a prolonged hospitalization because of secondary developmental
and respiratory issues. He continued to require
mechanical ventilation and underwent a tracheostomy on DOL 112. The patient was discharged
home on DOL 284 on a laptop ventilator.
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DISCUSSION
Surgical site infections remain a serious and
frequent complication of cardiac surgery. Of
particular concern are deep sternal wound infections and mediastinitis that can lead to significant
morbidity and mortality. The incidence of sternal
wound infections has been shown to be greater in
neonates (5.5%) than in older children (0.5%) and
has been associated with increased morbidity and
mortality in neonates.11 Incisional cellulitis and
fever are common signs of sternal wound infection in children, and in multiple series, Staphylococcus aureus and Staphylococcus epidermidis were
the most common pathogens.3-5,11-14
Risk factors for sternal wound infection in
children who have undergone cardiac surgery
include younger age, prolonged ventilation,
length of surgery, duration of central venous
catheterization, and deep hypothermic circulatory arrest.4,14,15 Our patient had multiple risk factors for infection. After the initial CoA repair, our
patient underwent surgical repair of his ASD and
VSD and had progressive heart failure in addition
to a prolonged need for mechanical ventilation.
Repair of the ASD and VSD required CPB with
moderate hypothermia. The use of CPB with
hypothermia may result in decreased immune
function postoperatively. Decreased immune
function may also occur because of prolonged
periods of diminished cardiac output coupled
with the young age of the patient.16
Treatment for deep sternal wound infection,
mediastinitis, and sternal osteomyelitis include
both surgical debridement and prolonged antibiotic therapy.11-13,17-19 Optimization of antibiotic
dosing is critical. Nafcillin, a beta-lactam antibiotic, exhibits time-dependent bacterial killing;
the amount of time the drug serum concentration is above the MIC is the main predictor of
efficacy.20,21 Bacteria regrowth can occur when the
drug serum concentration falls below the MIC.21
In children, nafcillin is typically dosed every six
hours, but this empiric dosing strategy may not
optimize the duration of drug exposure at the
source of infection in cases of deep sternal wound
infection such as osteomyelitis. Rather, relative
to the MIC, continuous infusion of nafcillin—as
with other beta-lactam antibiotics—may more
reliably provide adequate drug concentrations
at the site of infection.21,22 Although optimization of antibiotic dosing is critical in patients
52

with surgical wound infections, no reports have
been published about the continuous infusion
of antibiotics in children with secondary sternal
osteomyelitis.
Continuous infusion of beta-lactam antibiotics
such as nafcillin, piperacillin-tazobactam, and
ceftazidime is used in adult patients to optimize
each drug’s pharmacodynamic profile, to take
advantage of their convenience, and to reduce
the consumption of health care resources.20,22,23
Compared with intermittent dosing, this administration method has been shown to lead to cost
reductions.24,25 Reports of the continuous infusion of nafcillin in children are unavailable, but
the medical literature regarding this population
includes a few reports of other beta-lactam antibiotics and vancomycin being dosed as continuous infusions for indications other than sternal
osteomyelitis.6-8 Dalle and colleagues studied the
pharmacokinetic profile of ceftazidime continuously administered by IV in 20 febrile children
(median age, 5.4 years) who had neutropenia.7
Administration of a 65 mg/kg loading dose and
continuous infusion of ceftazidime (200 mg/
kg/d) resulted in mean serum concentrations
of 30.4-33 mg/L at 23-43 hours after initiation of
the infusion.7 Authors of another study reported
the efficacy of the continuous infusion of ceftazidime in 14 children (mean age, 12.6 years) who
had cystic fibrosis.8 Compared with ceftazidime
administered at 200 mg/kg/day 3 times a day,
the continuous infusion of ceftazidime at 100
mg/kg/d provided similar effects on pulmonary,
inflammatory, and nutritional status markers.8
Continuous infusions were well tolerated in
both studies.7,8 Vancomycin, cefuroxime, and
piperacillin-tazobactam also have been administered successfully as continuous infusions in
13 children, aged 2 months to 14 years, who
were treated for persistent, central intravenous
catheter-related infections due to Gram-positive
organisms.6
After multiple cultures tested positive for
MSSA, including a positive result for a wound
specimen that was taken while the patient was
receiving intermittent administration of nafcillin,
the continuous infusion of nafcillin was initiated
to optimize our patient’s nafcillin exposure. Although the medical literature includes reports of
children being treated with continuous infusions
of other beta-lactam antibiotics or vancomycin,
which have shown activity against MSSA, we
J Pediatr Pharmacol Ther 2010 Vol. 15 No. 1 • www.jppt.org
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elected to use nafcillin for our patient because of
the narrow spectrum of bacterial coverage and
the drug’s effectiveness against MSSA. We considered switching to an intermittent dosing regimen of every 4 hours rather than the continuous
infusion of nafcillin. However, given the nursing
and pharmacy resources required for intermittent
administration versus continuous infusion and
the anticipated prolonged duration of therapy,
we elected to administer nafcillin as a continuous
infusion. One bag containing a 24-hour supply
(nafcillin 24 mg/mL in 5% dextrose) was compounded daily by the inpatient pharmacy, and
the nursing staff changed the infusion once per
day to limit IV line interruptions. The total daily
dose of nafcillin was divided by 24 hours and
administered as a continuous infusion. Specific
nafcillin concentrations were not targeted. The
benefit of such concentrations is questionable
since our patient’s infection involved primary
bone and was not a blood stream infection. Also,
our laboratory was not able to analyze serum nafcillin concentrations; hence, samples would have
to be sent to a referral laboratory. The significant
delay in acquiring results diminished the utility
of trying to active certain concentrations.

2.
3.

4.

5.

6.

7.

CONCLUSIONS
To our knowledge, our case is the first report
of the use of a continuous infusion of nafcillin in
an infant who had sternal osteomyelitis after cardiovascular surgery. The diagnosis of the sternal
wound infection was confirmed using laboratory
and clinical criteria. The infection did not respond
to initial antimicrobial therapy administered
via a traditional dosing strategy. After receiving
surgical debridement and continuous infusion
nafcillin, the patient was successfully treated.
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